Related Experiment Video
Updated: Oct 19, 2026

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
Published on: November 17, 2023
Qualitative study on barriers and facilitators to genetic testing in Hispanic patients with prostate cancer
Perla Chebli1, Tatiana Sanchez Nolasco1,2, Mariana Rangel Camacho1,2
1From the Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
Background:
Despite the importance of germline genetic evaluation in prostate cancer (PCa), fewer U.S. Hispanic patients receive it.
Methods:
We conducted semi-structured in-depth interviews with U.S. Hispanic patients with PCa in English or Spanish on facilitators and barriers to germline genetic testing.
Results:
Barriers and facilitators were multidimensional. Key facilitators include family benefit, actionability, trust in clinicians, bilingual educational materials and insurance coverage; whereas key barriers include confusion with other tests, fear of negative implications, low awareness and limited clinician-led counseling.
Conclusions:
Bilingual informational materials, public messaging, and greater clinician education are needed to promote equity in PCa genetic evaluation.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Surveys
Principles of Pharmacogenetics: Types of Genetic Variants
